Chinese english Germany Japanese Korea

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine Struktur
1171893-98-3
CAS-Nr.
1171893-98-3
Englisch Name:
N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine
Synonyma:
N-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-PYRIDINEMETHANAMINE;3-Pyridinemethanamine, N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine
CBNumber:
CB52718850
Summenformel:
C13H21BN2O2
Molgewicht:
248.13
MOL-Datei:
1171893-98-3.mol
Request For Quotation

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine Eigenschaften

Sicherheit

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine Chemische Eigenschaften,Einsatz,Produktion Methoden

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jilin Chinese Academy of Sciences-yanshen Technology 		+undefined18143011203
 info@chemextension.com China 42057 58
Tetranov Biopharm 13526569071
 sales@leadmedpharm.com China 7901 64
Shanghai Rong Lin Medical Technology Co., Ltd. 18602194589
 lincy-110@163.com China 833 58
Jilin Chinese Academy of Sciences-yanshen Technology 18143011203
 ET-market@chemextension.com China 41859 58
  • N-Methyl-1-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)MethanaMine
  • N-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-PYRIDINEMETHANAMINE
  • 3-Pyridinemethanamine, N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
  • 1171893-98-3
Copyright 2019 © ChemicalBook. All rights reserved